A peptide-based adjuvant therapy to reduce the toxicity of Amphotericin B (2021–2023)

Grant type:
Gilead Sciences Research Scholars Program in Anti-Fungals
Researchers:
  • Senior Lecturer
    School of Chemistry and Molecular Biosciences
    Faculty of Science
Funded by:
Gilead Sciences Inc